VTN and multiple sclerosis: We have previously shown both to be present at high levels in multiple sclerosis lesions [41], while others have shown these complement proteins to be elevated in the blood and CSF of people with multiple sclerosis versus controls, and the be relevant in predictions of disability outcomes [42, 43].